Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,755 | 114 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $754.68 | 31 | $0 (2024) |
| Novo Nordisk Inc | $487.83 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $440.36 | 16 | $0 (2024) |
| PFIZER INC. | $216.33 | 6 | $0 (2023) |
| Lilly USA, LLC | $198.60 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $174.52 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $96.43 | 4 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $55.90 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $53.01 | 3 | $0 (2023) |
| Exact Sciences Corporation | $50.45 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $688.19 | 28 | ABBVIE INC. ($302.78) |
| 2023 | $973.44 | 35 | ABBVIE INC. ($298.57) |
| 2022 | $566.61 | 24 | Novo Nordisk Inc ($147.91) |
| 2021 | $526.67 | 27 | Novo Nordisk Inc ($149.19) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Obesity | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $116.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Gastroenterology | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $37.45 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Respiratory | ||||||
| 04/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Obesity | ||||||
| 02/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Biological | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 278 | 500 | $121,570 | $39,867 |
| 2022 | 9 | 562 | 972 | $195,110 | $67,407 |
| 2021 | 8 | 303 | 523 | $109,930 | $38,998 |
| 2020 | 5 | 198 | 303 | $55,130 | $15,041 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 235 | $64,625 | $17,789 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 142 | $40,470 | $15,656 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $7,400 | $3,982 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 35 | $5,250 | $1,967 | 37.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 51 | $3,825 | $472.85 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 381 | $104,775 | $28,580 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 131 | $37,335 | $14,907 | 39.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 105 | 176 | $14,080 | $7,459 | 53.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $11,800 | $6,454 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 78 | $11,700 | $4,746 | 40.6% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 24 | 24 | $8,400 | $4,247 | 50.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 66 | 69 | $5,175 | $652.41 | 12.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 35 | $1,750 | $336.89 | 19.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 12 | 19 | $95.00 | $24.76 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 131 | 274 | $75,350 | $24,399 | 32.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 50 | $14,250 | $6,381 | 44.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 62 | $9,300 | $3,909 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $4,800 | $2,795 | 58.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 18 | $1,530 | $714.78 | 46.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 41 | $2,050 | $409.59 | 20.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 34 | 34 | $2,550 | $357.00 | 14.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 11 | 20 | $100.00 | $33.20 | 33.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 144 | $39,600 | $10,267 | 25.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 63 | 80 | $12,000 | $3,860 | 32.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 15 | $1,275 | $474.15 | 37.2% |
About Shawnee Thomas, CRNP
Shawnee Thomas, CRNP is a Registered Nurse healthcare provider based in Waldorf, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952814204.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shawnee Thomas, CRNP has received a total of $2,755 in payments from pharmaceutical and medical device companies, with $688.19 received in 2024. These payments were reported across 114 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,755).
As a Medicare-enrolled provider, Thomas has provided services to 1,341 Medicare beneficiaries, totaling 2,298 services with total Medicare billing of $161,313. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Waldorf, MD
- Active Since 11/08/2017
- Last Updated 11/20/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1952814204
Products in Payments
- UBRELVY (Drug) $401.86
- QULIPTA (Drug) $352.82
- JARDIANCE (Drug) $209.75
- TRELEGY ELLIPTA (Drug) $150.35
- Wegovy (Drug) $146.94
- Rybelsus (Drug) $125.65
- LOKELMA (Drug) $123.98
- FARXIGA (Drug) $123.50
- PAXLOVID (Drug) $114.65
- Ozempic (Drug) $102.72
- Saxenda (Drug) $93.30
- ELIQUIS (Drug) $64.58
- AIRSUPRA (Drug) $63.36
- TRULICITY (Drug) $58.59
- NURTEC ODT (Drug) $55.90
- BREZTRI (Drug) $51.68
- Cologuard Collection Kit (Device) $50.45
- Kerendia (Drug) $47.00
- Veozah (Drug) $41.83
- COMIRNATY (Biological) $37.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Waldorf
Gabriela Amaya, Fnp-Bc, FNP-BC
Registered Nurse — Payments: $1,223
Rene Johnson, Crnp, CRNP
Registered Nurse — Payments: $760.25
Ashley Siemonh, N.p, N.P
Registered Nurse — Payments: $636.79
Ms. Brittany Sewell
Registered Nurse — Payments: $368.20
Jeanne Beauchamp, Arnp, ARNP
Registered Nurse — Payments: $299.58
Cynthia Glover-Singleton, Rn, Pmhnp-Bc, RN, PMHNP-BC
Registered Nurse — Payments: $198.34